UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
FORM 8-K/A
CURRENT REPORT
Pursuant to Section 13 or 15(d) of
The Securities Exchange Act of 1934
Date of Report (Date of earliest event reported)
August 13, 2013
TEARLAB CORPORATION
(Exact name of registrant as specified in its charter)
Delaware | 000-51030 | 59-343-4771 | ||
(State or other jurisdiction of incorporation) | (Commission File Number) | (IRS Employer |
9980 Huennekens St., Ste 100
San Diego, CA 92121
(Address of principal executive offices, including zip code)
(858) 455-6006
(Registrant’s telephone number, including area code)
7360 Carroll Rd, Ste 200
San Diego, CA 92121
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
[ ] Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
[ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
[ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
[ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Explanatory Note
This report amends our Current Report on Form 8-K filed on August 13, 2013. The prior version of this Form 8-K included a version of our press release that is being re-filed herewith to correct certain numbers contained in our Consolidated Statements of Operations and Comprehensive Loss and Consolidated Balance Sheet. Such financials were properly disclosed in our Quarterly Report on Form 10-Q filed on August 13, 2013.
Item 2.02. Results of Operations and Financial Condition
On August 13, 2013, TearLab Corporation issued a press release announcing financial results for its second quarter ended June 30, 2013. A copy of this press release is attached hereto as Exhibit 99.1.
The information in this Item 2.02 and Exhibit 99.1 shall not be deemed “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934 (the “Exchange Act”) and shall not be deemed to be incorporated by reference into any filing under the Securities Act of 1933, or the Exchange Act, except to the extent that we specifically incorporate it by reference.
Item 9.01. Financial Statements and Exhibits.
(d) Exhibits.
Exhibit No. |
| Description |
99.1 |
| Press Release of TearLab Corporation dated August 13, 2013. |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
TEARLAB CORPORATION | |||
By: | /s/ William G. Dumencu | ||
William G. Dumencu Chief Financial Officer | |||
Date: August 14, 2013
EXHIBIT INDEX
Exhibit | Description | |
99.1 |
| Press Release of TearLab Corporation dated August 13, 2013. |